← Browse by Condition
Medical Condition
colorectal cancer metastatic
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06764680 Phase 2
Recruiting
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
Enrollment
57 pts
Location
China
Sponsor
Sun Yat-sen University
NCT06605430 Phase 2
Recruiting
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
Enrollment
64 pts
Location
United States
Sponsor
HealthPartners Institute
NCT06763029 Phase 2
Recruiting
Irinotecan Liposomes Combined with Cetuximab + Vermofenib in First-line Failure of Advanced Colorectal Cancer
Enrollment
36 pts
Location
China
Sponsor
Fudan University
NCT07012954 Phase 1, Phase 2
Recruiting
ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC
Enrollment
64 pts
Location
China
Sponsor
Sun Yat-sen University
NCT05913674 Phase 2
Recruiting
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Enrollment
25 pts
Location
Canada
Sponsor
Ciusss de L'Est de l'Île de Mo...
NCT05759728 Phase 1, Phase 2
Recruiting
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Enrollment
45 pts
Location
Australia
Sponsor
Carina Biotech Limited
NCT06379399 Phase 1, Phase 2
Recruiting
Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC
Enrollment
26 pts
Location
China
Sponsor
Wangxia LV
NCT06447727
Recruiting
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Enrollment
30 pts
Location
China
Sponsor
Zhongda Hospital